- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Isoliquiritigenin is a natural compound found in licorice root and is used in the treatment of various types of cancer. It has been studied for its potential to inhibit the growth of cancer cells, as well as its ability to reduce the side effects of chemotherapy. Isoliquiritigenin has been found to be effective in treating a variety of cancers, including breast, lung, and prostate cancer. It has also been studied for its potential to reduce the risk of metastasis.
Isoliquiritigenin is available in a variety of forms, including tablets, capsules, and liquid extracts. It is also available as an ingredient in some herbal supplements.
Several companies are involved in the Isoliquiritigenin market, including Sun Pharma, Cipla, and Dr. Reddy's Laboratories. Other companies involved in the market include Zydus Cadila, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more